To enhance the care you currently provide, and to help reduce risks associated with COVID-19 multi-drug interactions and other high-risk medication regimens, Tabula Rasa HealthCare (TRHC) is now offering MedWise Science decision support tools integrated directly within the PrescribeWellness software solution.
MedWise Decision Support Program
Fill out the form to get started today:
Read more about MedWise in peer-reviewed literature
MedWise Risk Score
A retrospective, peer-reviewed study involving nearly 2,000 patients was published validating the association between the MedWise Risk Score™ and Adverse Drug Events (ADEs) along with medical costs per unit.
The study found that every point increase in the MRS corresponded to an 8.6% increase in the odds of having one or more ADEs per year, $1037 USD in additional annual medical spending, 3.2 additional ED visits per 100 patients per year, and 2.1 additional hospitalizations per 100 patients per year. Reducing the MedWise Risk Score, means fewer ADEs, ED visits, hospitalizations, and associated medical costs.